Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
| Autor: | Inoue, A. *, Kobayashi, K., Maemondo, M., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., Fujita, Y., Okinaga, S., Hirano, H., Yoshimori, K., Harada, T., Saijo, Y., Hagiwara, K., Morita, S., Nukiwa, T. |
|---|---|
| Zdroj: | In Annals of Oncology January 2013 24(1):54-59 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|